Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3690-3697

  Morandi, Barbara ^a   Costa, Roberta ^b   Falco, Michela ^c   Parolini, Silvia ^d   De Maria, Andrea ^e   Ratto, Giovanni ^f   Mingari, Maria Cristina ^a,e   Melioli, Giovanni ^c   Moretta, Alessandro ^e,g   Ferlazzo, Guido ^a,h  

^a UNIVERSITY OF GENOA   (Italy)

^b C Arrigo Children's Hospital   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f S CROCE E CARLE HOSPITAL   (Italy)

^g Centro di Eccellenza per la Ricerca Biomedica   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD48 ANTIGEN; GAMMA INTERFERON; GLYCOSYLPHOSPHATIDYLINOSITOL; LYMPHOCYTE ACTIVATION MOLECULE RELATED RECEPTOR; PROTEIN 2B4; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; BONE MARROW; BONE MARROW CELL; CELL ACTIVATION; CELL COMMUNICATION; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHADENITIS; LYMPHOPROLIFERATIVE DISEASE; MONOCYTE; NATURAL KILLER CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; THYMUS; TISSUE SPECIFICITY; X CHROMOSOME LINKED DISORDER;

EID: 24744456552     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3690     Document Type: Article

References (48)

1. Kishimoto, T., H. Kikutani, A. E. G. Kr. von dem Borne, S. M. Goyert, D. Y. Mason, M. Miyasaka, L. Moretta, K. Okumura, S. Shaw, T. A. Springer, et al. 1998. Leukocyte Typing VI: White Cell Differentiation Antigens. Garland, New York, p. 509.
2. Nakajima, H., M. Cella, H. Langen, A. Friedlein, and M. Colonna. 1999. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 29: 1676-1683.
3. + T cell proliferation by 2B4/CD48 interactions. J. Immunol. 167: 6706-6710.
4. Tangye, S. G., H. Cherwinski, L. L. Lanier, and J. H. Phillips. 2000. 2B4-mediated activation of human natural killer cells. Mol. Immunol. 37: 493-501.
5. Chuang, S. S., P. R. Kumaresan, and P. A. Mathew. 2001. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J. Immunol. 167: 6210-6216.
6. Sivori, S., M. Falco, E. Marcenaro, S. Parolini, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2002. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. USA 99: 4526-4531.
7. Parolini, S., C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. D. Ochs, H. Wolf, J. Y. Bonnefoy, R. Biassoni, et al. 2000. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192: 337-346.
8. Benoit, L., X. Wang, H. F. Pabst, J. Dutz, and R. Tan. 2000. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165: 3549-3553.
9. Morra, M., D. Howie, M. S. Grande, J. Sayos, N. Wang, C. Wu, P. Engel, and C. Terhorst. 2001. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu. Rev. Immunol. 19: 657-682.
10. Chen, R., F. Relouzat, R. Roncagalli, A. Aoukaty, R. Tan, S. Latour, and A. Veillette. 2004. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol. Cell. Biol. 24: 5144-5156.
11. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5: 405-411.
12. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Münz. 2002. Human dendritic cells activate resting NK cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-351.
13. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
14. Piccioli, D., S. Sbrana, E. Melandri, and N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195: 335-341.
15. Granucci, F., I. Zanoni, S. Feau, and P. Ricciardi-Castagnoli. 2003. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J. 22: 2546-2551.
16. Granucci, F., I. Zanoni, N. Pavelka, S. L. Van Dommelen, C. E. Andoniou, F. Belardelli, M. A. Degli Esposti, and P. Ricciardi-Castagnoli. 2004. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 200: 287-295.
17. Munz, C., T. Dao, G. Ferlazzo, M. A. de Cos, K. Goodman, and J. W. Young. 2005. Mature myeloid dendritic cell subsets have distinct roles for the activation and viability of circulating human natural killer cells. Blood 105: 266-273.
18. Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowig, G. Bougras, W. A. Muller, L. Moretta, and C. Munz. 2004. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101: 16606-16611.
19. Terme, M., E. Tomasello, K. Maruyama, F. Crepineau, N. Chaput, C. Flament, J. P. Marolleau, E. Angevin, E. F. Wagner, B. Salomon, et al. 2004. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules. J. Immunol. 172: 5957-5966.
20. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Arico, L. Moretta, and A. Moretta. 2005. NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering. Blood 106: 566-571.
21. + T cells. J. Immunol. 163: 3597-3604.
22. + progenitors. Adv. Exp. Med. Biol. 417: 15-19.
23. + progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-α are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells. J. Immunother. 23: 48-58.
24. Wilson, J. L., L. C. Heffler, J. Charo, A. Scheynius, M. T. Bejarano, and H. G. Ljunggren. 1999. Targeting of human dendritic cells by autologous NK cells. J. Immunol. 163: 6365-6370.
25. Pende, D., S. Parolini, A. Pessino, S. Sivori, R. Augugliaro, L. Morelli, E. Marcenaro, L. Accame, A. Malaspina, R. Biassoni, et al. 1999. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190: 1505-1516.
26. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223.
27. Sivori, S., S. Parolini, M. Falco, E. Marcenaro, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2000. 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30: 787-793.
28. Cella, M., C. Dohring, J. Samaridis, M. Dessing, M. Brockhaus, A. Lanzavecchia, and M. Colonna. 1997. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185: 1743-1751.
29. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5: 919-923.
30. MacDonald, K. P., D. J. Munster, G. J. Clark, A. Dzionek, J. Schmitz, and D. N. Hart. 2002. Characterization of human blood dendritic cell subsets. Blood 100: 4512-4520.
31. Ferlazzo, G., and C. Munz. 2004. NK cell compartments and their activation by dendritic cells. J. Immunol. 172: 1333-1339.
32. Ferlazzo, G., D. Thomas, S. L. Lin, K. Goodman, B. Morandi, W. A. Muller, A. Moretta, and C. Münz. 2004. The abundant NK cells in human lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172: 1455-1462.
33. Cooper, M. A., T. A. Fehniger, A. Fuchs, M. Colonna, and M. A. Caligiuri. 2004. NK cell and DC interactions. Trends Immunol. 25: 47-52.
34. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101: 3052-3057.
35. Lee, K. M., M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar. 2004. 2B4 Acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 199: 1245-1254.
36. Barratt-Boyes, S. M., M. I. Zimmer, L. A. Harshyne, E. M. Meyer, S. C. Watkins, S. Capuano III, M. Murphey-Corb, L. D. Falo, Jr., and A. D. Donnenberg. 2000. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J. Immunol. 164: 2487-2495.
37. 2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100: 1354-1361.
38. De Vries, I. J., D. J. Krooshoop, N. M. Scharenborg, W. J. Lesterhuis, J. H. Diepstra, G. N. Van Muijen, S. P. Strijk, T. J. Ruers, O. C. Boerman, W. J. Oyen, et al. 2003. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 63: 12-17.
39. Blazar, B. R., P. A. Taylor, A. Panoskaltsis-Mortari, H. Yagita, J. S. Bromberg, and D. A. Vallera. 1998. A critical role for CD48 antigen in regulating alloengraftment and lymphohematopoietic recovery after bone marrow transplantation. Blood 92: 4453-4463.
40. Koopman, L. A., H. D. Kopcow, B. Rybalov, J. E. Boyson, J. S. Orange, F. Schatz, R. Masch, C. J. Lockwood, A. D. Schachter, P. J. Park, et al. 2003. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198: 1201-1212.
41. Moffett-King, A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2: 656-663.
42. Kammerer, U., A. O. Eggert, M. Kapp, A. D. McLellan, T. B. Geijtenbeek, J. Dietl, Y. van Kooyk, and E. Kampgen. 2003. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol. 162: 887-896.
43. Moretta, A. 2002. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2: 957-964.
44. + effector αβ T cells. J. Immunol. 167: 6165-6170.
45. Kumar, V., and M. E. McNerney. 2005. A new self: MHC-class-1-independent natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5: 363-374.
46. Vaidya, S. V., S. E. Stepp, M. E. McNerney, J. K. Lee, M. Bennett, K. M. Lee, C. L. Stewart, V. Kumar, and P. A. Mathew. 2005. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J. Immunol. 174: 800-807.
47. Veillette, A. 2004. SLAM family receptors regulate immunity with and without SAP-related adaptors. J. Exp. Med. 199: 1175-1178.
48. McNerney, M. E., D. Guzior, and V. Kumar. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK cell self-tolerance in mice. Blood. In press. 3698-3706